
Gregg Curtis Fonarow MD
Heart Failure & Transplantation, Preventive Cardiology
Professor of Medicine, UCLA
Join to View Full Profile
100 Medical Plaza, Suite 630Los Angeles, CA 90095
Phone+1 310-825-8816
Fax+1 310-825-8816
Dr. Fonarow is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Gregg Fonarow is a cardiologist in Los Angeles, CA and is affiliated with Ronald Reagan UCLA Medical Center. He received his medical degree from David Geffen School of Medicine at UCLA and has been in practice 30 years. He specializes in heart failure & transplantation, quality of care, and preventive cardiology and is experienced in general cardiology, preventive cardiology, heart failure, and critical care medicine. He is co-Chief of the UCLA Division of Cardiology.
Education & Training
- UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Cardiovascular Disease, 1990 - 1993
- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 1987 - 1990
- David Geffen School of Medicine at UCLAClass of 1987
Certifications & Licensure
- CA State Medical License 1988 - 2026
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Chairman's Award American Heart Association, 2017
- Fellow Heart Failure Society of America Heart Failure Society of America, 2015
- Distinguished Clinical Research Award Clinical Research Forum, 2014
- Join now to see all
Clinical Trials
- IMPROVE HF: Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting Start of enrollment: 2005 May 01
Publications & Presentations
PubMed
- Trends in Cardiac Arrest Among Heart Failure Patients Aged 25 and Older in the United States: Insights from the CDC WONDER Database.Abdullah Naveed Muhammad, Sivaram Neppala, Himaja Dutt Chigurupati, Ahila Ali, Muhammad Omer Rehan
The American Journal of Cardiology. 2025-06-15 - 1 citationsInitiation and sequencing of guideline-directed medical therapy for heart failure across the ejection fraction spectrum.Izza Shahid, Muhammad Shahzeb Khan, Javed Butler, Gregg C Fonarow, Stephen J Greene
Heart Failure Reviews. 2025-05-01 - Higher levels of glucose within the normal range and cardiovascular risk: A landscape beyond diabetes and prediabetes.Moein Ebrahimi, Gregg C Fonarow
American Heart Journal. 2025-05-01
Journal Articles
- Expediting the Benefits of Sodium-Glucose Cotransporter-2 Inhibitors for Heart Failure—There Is No Time for DelayGregg C Fonarow, Clyde W Yancy, JAMA Cardiology
- National Trends in Heart Failure Hospitalizations and Readmissions from 2010 to 2017Manyoo A Agarwal, Gregg C Fonarow, Boback Ziaeian, JAMA Cardiology
- Applicability of US Food and Drug Administration Labeling for Dapagliflozin to Patients with Heart Failure with Reduced Ejection Fraction in US Clinical PracticeMuthiah Vaduganathan, Javed Butler, Paul A Heidenreich, Michelle M Kittleson, Anjali Tiku Owens, Pamela N Peterson, Clyde W Yancy, Gregg C Fonarow, JAMA Cardiology
- Join now to see all
Authored Content
- VERTIS CV Trial: Heterogeneity in Clinical Benefits of Sodium-Glucose Cotransporter-2 Inhibitors for Patients with Type II Diabetes?September 2020
- Cost-Effectiveness of Sacubitril-Valsartan in Hospitalized Patients Who Have Heart Failure with Reduced Ejection FractionAugust 2020
- Cost-Effectiveness of Sacubitril-Valsartan in Hospitalized Patients Who Have Heart Failure with Reduced Ejection FractionAugust 2020
- Coronavirus Disease 2019 (COVID-19) and the Heart—Is Heart Failure the Next Chapter?July 2020
- Association Between Thrombolytic Door-to-Needle Time and 1-Year Mortality and Readmission in Patients with Acute Ischemic StrokeJune 2020
- Association of Coronavirus Disease 2019 (COVID-19) with Myocardial Injury and MortalityMarch 2020
- Association of Coronavirus Disease 2019 (COVID-19) with Myocardial Injury and MortalityMarch 2020
- Association of Coronavirus Disease 2019 (COVID-19) with Myocardial Injury and MortalityMarch 2020
- Association of Coronavirus Disease 2019 (COVID-19) with Myocardial Injury and MortalityMarch 2020
- 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure with Reduced Ejection Fraction A Report of the American College of Cardiology Task Force on Expert Consensus Decision PathwaysJanuary 2018
- 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure with Reduced Ejection FractionDecember 2017
- 2017 AHA/ACC Clinical Performance and Quality Measures for Adults with ST-Elevation and Non–ST-Elevation Myocardial Infarction A Report of the American College of Cardiology/American Heart Association Task Force on Performance MeasuresOctober 2017
- Join now to see all
Press Mentions
- American Heart Association Program Leads to Substantial Improvements in Stroke CareApril 1st, 2025
- Q&A: ‘Normal’ Blood Glucose May Still Increase Risk for Heart DiseaseMarch 10th, 2025
- FINEARTS-HF Analysis Shows Finerenone Reduces Worsening HF Symptoms in OutpatientsMarch 5th, 2025
- Join now to see all
Professional Memberships
- Fellow
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: